Guangdong Raynovent Biotech Co., Ltd
Clinical trials sponsored by Guangdong Raynovent Biotech Co., Ltd, explained in plain language.
-
New obesity drug RAY1225 enters early human testing
Disease control CompletedThis early-stage trial tested a new drug, RAY1225, in 68 healthy and obese adults in China. The main goal was to check if the drug is safe and how the body processes it. Researchers also looked at changes in body weight and waist size as early signs of effectiveness.
Phase: PHASE1 • Sponsor: Guangdong Raynovent Biotech Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New flu pill for kids shows promise in early trial
Disease control CompletedThis study tested a new flu medicine called ZSP1273 in 72 children aged 2 to 17 with influenza A. The goal was to see how safe it is, how the body processes it, and whether it helps reduce flu symptoms. The trial took place in China and has already been completed.
Phase: PHASE2 • Sponsor: Guangdong Raynovent Biotech Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC